IntraBio Reports Statistically Significant and Clinically Meaningful Improvements in the Use of IB1001 For Treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease)
August 19, 2021

August 19, 2021
August 12, 2021
August 3, 2021
June 28, 2021
June 18, 2021
June 15, 2021
June 1, 2021
May 27, 2021
May 6, 2021
August 20, 2026
Laboratory automation veteran brings nearly three decades of commercial and technical leadership to drive growth of Thomas Scientific's technical sale...
August 17, 2026
Rapid access to custom liquid and powder media helps scientists move from formulation design to process decisions faster, while supporting a clearer p...
August 11, 2026
Sciensus, one of the UK's largest providers of home-based healthcare, today announced a new agreement with global oncology company Novocure to deliver...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225